In addition, the increase in isocitrate dehydrogenase (IDH)-1 and IDH-2 activity observed in BPMR2-mutated VECs is identical with the increased serum IDH activity of PAH patients (Fessel et al., 2012). The gene discussed is IDH2; the disease is pulmonary arterial hypertension.